A neutralizing epitope of human papillomavirus type 11 is principally described by a continuous set of residues which overlap a distinct linear, surface-exposed epitope

Journal of Virology

Volumn 71, Issue 5, 1997, Pages 3834-3839

  Ludmerer, Steven W ^a   Benincasa, Diana ^a   Mark III, George E ^a   Christensen, Neil D ^b  

^a MERCK RESEARCH LABORATORIES   (United States)

^b PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSID PROTEIN; EPITOPE; MONOCLONAL ANTIBODY; VIRUS PROTEIN;

AMINO ACID SUBSTITUTION; ANTIGEN BINDING; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN ASSEMBLY; RECEPTOR BINDING; SEQUENCE ANALYSIS; VIRUS INFECTIVITY; VIRUS NEUTRALIZATION; VIRUS TYPING; WART VIRUS;

EID: 0030896195     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.5.3834-3839.1997     Document Type: Article

References (46)

1. Barlow, D. J., M. S. Edwards, and J. M. Thornton. 1986. Continuous and discontinuous protein antigenic determinants. Nature 332:747-748.
2. Benincasa, D., M. Silberlkang, G. E. Mark III, and S. W. Ludmerer. 1996. Rapid, high-level transient expression of papillomavirus-like particles in insect cells. BioTechniques 20:890-895.
3. Blundell, T. L., B. L. Sibanda, M. J. E. Sternberg, and J. M. Thornton. 1987. Knowledge-based prediction of protein structures and the design of novel molecules. Nature 326:347-352.
4. Breitburd, F., R. Kirnbauer, N. L. Hubbert, B. Nonnenmacher, C. Trin-Dinh-Desmarquet, G. Orth, J. T. Schiller, and D. R. Lowy. 1995. Immunization with viruslike particles from cottontail rabbit papillomavirus (CRPV) can protect against experimental CRPV infection. J. Virol. 69:3959-3963.
5. Campo, M. S. 1991. Vaccination against papillomavirus. Cancer Cells 3:421-426.
6. Christensen, N., and S. Ludmerer. Unpublished observations.
7. Christensen, N. D., J. Dillner, C. Eklund, J. J. Carter, G. C. Wifp, C. A. Reed, N. M. Cladel, and D. A. Galloway. 1996. Surface conformational and linear epitopes on HPV-16 and HPV-18 virus-like particles as defined by monoclonal antibodies. Virology 223:174-184.
8. Christensen, N. D., W. Hurni, and S. W. Ludmerer. Unpublished observations.
9. Christensen, N. D., and J. W. Kreider. 1991. Neutralization of CRPV infectivity by monoclonal antibodies that identify conformational epitopes on intact virions. Virus Res. 21:169-179.
10. Christensen, N. D., J. W. Kreider, N. M. Cladel, S. D. Patrick, and P. A. Welsh. 1990. Monoclonal antibody-mediated neutralization of infectious human papillomavirus type 11. J. Virol. 64:5678-5681.
11. Christensen, N. D., C. A. Reed, N. M. Cladel, R. Han, and J. W. Kreider. 1996. Immunization with virus-like particles induces long-term protection of rabbits against challenge with cottontail rabbit papillomavirus. J. Virol. 70: 960-965.
12. Dartmann, K., E. Schwarz, L. Gissmann, and H. zur Hausen. 1986. The nucleotide sequence and genome organization of human papillomavirus type 11. Virology 151:124-130.
13. Dimmock, N. J. 1995. Update on the neutralisation of animal viruses. Rev. Med. Virol. 5:165-179.
14. Galloway, D. A. 1996. HPV serology: another update, p. 113-119. In C. Lacy (ed.), Papillomavirus reviews: current research on papillomaviruses. Leeds University Press, Leeds, United Kingdom.
15. Gissmann, L., H. J. Dien, H. J. Schultz-Coulun, and H. zur Hausen. 1982. Molecular cloning and characterization of human papillomavirus DNA derived from a laryngeal papilloma. J. Virol. 44:393-400.
16. Gomez-Puertas, P., F. Rodriguez, J. M. Oviedo, F. Ramiro-Ibanez, F. Ruiz-Gonzalvo, C. Alonso, and J. M. Escribano. 1996. Neutralizing antibodies to different proteins of African swine fever virus inhibit both virus attachment and internalization. J. Virol. 70:5689-5694.
17. Hagensee, M. E., N. Yaegashi, and D. A. Galloway. 1993. Self-assembly of human papillomavirus type 1 capsid proteins. J. Virol. 67:315-322.
18. Haywood, A. M. 1994. Virus receptors: binding, adhesion strengthening, and changes in viral structure. J. Virol. 68:1-5.
19. Heino, P., B. Skyldberg, M. Lehtinen, I. Rantala, B. Hagmar, J. W. Kreider, R. Kirnbauer, and J. Dillner. 1995. Human papillomavirus type 16 capsids expose multiple type-restricted and type-common antigenic epitopes. J. Gen. Virol. 76:1141-1153.
20. Hofmann, K. J., J. C. Cook, J. G. Joyce, D. R. Brown, L. D. Schultz, H. A. George, M. Rosolowsky, K. H. Fife, and K. V. Jansen. 1995. Sequence determination of human papillomavirus type 6a and assembly of virus-like particles in Saccharomyces cerevisiae. Virology 209:506-518.
21. Horsfall, A. C., F. C. Hay, A. J. Soltys, and M. G. Jones. 1991. Epitope mapping. Immunol. Today 12:211-213.
22. Jansen, K. U., M. Rosolowsky, S. D. Schultz, H. Z. Harkus, J. C. Cook, J. J. Donnelly, D. Martinez, R. W. Ellis, and A. R. Shaw. 1995. Vaccination with yeast expressed cottontail rabbit papillomavirus (CRPV) virus-like particles protects rabbits from CRPV-induced papilloma formation. Vaccine 13:1509-1514.
23. Jarrett, W. F. H., B. W. O'Neil, J. M. Gaukroger, H. M. Laird, K. T. Smith, and M. S. Campo. 1990. Studies on vaccination against papillomaviruses: a comparison of purified virus, tumour extract and transformed cells in prophylactic vaccination. Vet. Rec. 126:449-452.
24. Jarrett, W. F. H., B. W. O'Neil, J. M. Gaukroger, K. T. Smith, H. M. Laird, and M. S. Campo. 1990. Studies on vaccination against papillomaviruses: the immunity after infection and vaccination with bovine papillomaviruses of different types. Vet. Rec. 126:473-175.
25. Jarrett, W. F. H., K. T. Smith, B. W. O'Neil, J. M. Gaukroger, L. M. Chandrachud, G. J. Grindlay, G. M. McGarvie, and M. S. Campo. 1991. Studies on vaccination against papillomaviruses: prophylactic and therapeutic vaccination with recombinant structural proteins. Virology 184:33-42.
26. Kawase, M., G. Orth, S. Jablonska, C. Blanchet-Bardon, L.-A. Rueda, and M. Favre. 1996. Variability and phylogeny of the L1 capsid protein gene of human papillomavirus type 5: contribution of clusters of nonsynonymous mutations and of a 20-nucleotide duplication. Virology 221:189-198.
27. Kirnbauer, R., F. Booy, N. Cheng, D. R. Lowy, and J. T. Schiller. 1992. Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic. Proc. Natl. Acad. Sci. USA 89:12180-12184.
28. Kirnbauer, R., L. M. Chandrachud, B. W. O'Neil, E. R. Wagner, G. J. Grindlay, and A. Armstrong. 1996. Virus-like particles of bovine papillomavirus type 4 in prophylactic and therapeutic immunization. Virology 219:37-44.
29. Kirnbauer, R., J. Taub, H. Greenstone, R. Roden, M. Durst, L. Gissmann, D. R. Lowy, and J. T. Schiller. 1993. Efficient self-assembly of human papillomavirus type 16 L1 and L1-L2 into virus-like particles. J. Virol. 67:6929-6936.
30. Kreider, J. W., M. K. Howett, S. A. Wolfe, G. L. Bartlett, R. J. Zaino, T. V. Sedlacek, and R. Mortel. 1985. Morphological transformation in vivo of human uterine cervix with papillomavirus from condylomata acuminata. Nature 317:639-641.
31. Livnah, O. E., A. Stura, D. L. Johnson, S. A. Middleton, L. S. Mulcahy, N. C. Wrighton, W. J. Dower, L. K. Jolliffe, and I. A. Wilson. 1996. Functional mimicry of a protein hormone by a peptide agonist: the EPO receptor complex at 2.8 A○. Science 273:464-471.
32. Lowe, R., K. Jansen, and S. Ludmerer. Unpublished observations.
33. Ludmerer, S. Unpublished observations.
34. Ludmerer, S. W., D. Beníncasa, and G. E. Mark III. 1996. Two amino acid residues confer type specificity to a neutralizing, conformationally dependent epitope on human papillomavirus type 11. J. Virol. 70:4791-4794.
35. Muller, M., L. Gissmann, R. J. Cristiano, X. Y. Sun, I. H. Frazer, A. B. Jenson, A. Alonso, H. Zentgraf, and J. Zhou. 1995. Papillomavirus capsid binding and uptake by cells from different tissues and species. J. Virol. 69:948-954.
36. Qi, Y. M., S. W. Peng, K. Hengst, M. Evander, D. S. Park, J. Zhou, and I. H. Frazer. 1996. Epithelial cells display separate receptors for papillomavirus VLPs and for soluble L1 capsid protein. Virology 216:35-45.
37. Roden, R. B. S., H. L. Greenstone, R. Kirnbauer, F. P. Booy, J. Jessie, D. R. Lowy, and J. T. Schiller. 1996. In vitro generation and type-specific neutralization of a human papillomavirus type 16 virion pseudotype. J. Virol. 70: 5875-5883.
38. Roden, R. B. S., R. Kirnbauer, A. B. Jenson, D. R. Lowy, and J. T. Schiller. 1994. Interaction of papillomaviruses with the cell surface. J. Virol. 68:7260-7266.
39. Roden, R. B. S., E. M. Weissinger, D. W. Henderson, F. Booy, R. Kirnbauer, J. F. Mushinski, D. R. Lowy, and J. T. Schiller. 1994. Neutralization of bovine papillomavirus by antibodies to L1 and L2 capsid proteins. J. Virol. 68:7570-7574.
40. Rose, R. C., W. Bonnez, R. C. Reichman, and R. I. Garcea. 1993. Expression of human papillomavirus type 11 L1 protein in insect cells: in vivo and in vitro assembly of virus-like particles. J. Virol. 67:1936-1944.
41. Schiller, J. 1996. Presented at the 15th International Papillomavirus Conference, 1996.
42. Schiller, J. T., and M. M. Okun. 1996. Papillomavirus vaccines: current status and future prospects. Adv. Dermatol. 11:355-380.
43. Steward, M. W., C. M. Stanley, and O. E. Obeid. 1995. A mimotope from a solid-phase peptide library induces a measles virus-neutralizing and protective antibody response. J. Virol. 69:7668-7673.
44. Volpers, C., F. Unckell, P. Schirmacher, R. E. Streeck, and M. Sapp. 1995. Binding and internalization of human papiilomavirus type 33 virus-like particles by eukaryotic cells. J. Virol. 69:3258-3264.
45. Wrighton, N. C., F. X. Farrell, R. Chang, A. K. Kashyap, F. P. Barbone, L. S. Mulcahy, D. L. Johnson, R. W. Barrett, L. K. Jolliffe, and W. J. Dower. 1996. Small peptides as potent mimetics of the protein hormone erythropoietin. Science 273:458-463.
46. Zhou, J., S. Y. Sun, D. J. Stenzel, and I. H. Frazer. 1991. Expression of vaccinia recombinant HPV16 L1 and L2 ORF proteins in epithelial cells is sufficient for assembly of HPV virion-like particles. Virology 185:251-257.